Miromatrix Medical Inc.
MIRO · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $953 | $33 | $47 | $250 |
| % Growth | 2,783.5% | -28.9% | -81.4% | – |
| Cost of Goods Sold | $500 | $500 | $500 | $250 |
| Gross Profit | $453 | -$467 | -$453 | $0 |
| % Margin | 47.6% | -1,412.1% | -974.6% | 0% |
| R&D Expenses | $18,303 | $10,751 | $7,281 | $6,267 |
| G&A Expenses | $8,720 | $4,643 | $2,109 | $2,436 |
| SG&A Expenses | $8,720 | $4,643 | $2,109 | $2,436 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $3,676 | $706 | -$577 | -$143 |
| Operating Expenses | $30,699 | $16,100 | $8,813 | $8,560 |
| Operating Income | -$30,246 | -$16,960 | -$10,259 | -$8,992 |
| % Margin | -3,172.2% | -51,289.9% | -22,047.2% | -3,596.7% |
| Other Income/Exp. Net | $404 | $2,294 | -$51 | -$535 |
| Pre-Tax Income | -$29,960 | -$14,671 | -$10,310 | -$9,527 |
| Tax Expense | $48 | $285 | -$1,593 | -$6,457 |
| Net Income | -$30,008 | -$14,956 | -$8,716 | -$3,070 |
| % Margin | -3,147.2% | -45,230% | -18,732.7% | -1,228.1% |
| EPS | -1.45 | -0.73 | -0.82 | -0.29 |
| % Growth | -98.6% | 11% | -182.8% | – |
| EPS Diluted | -1.45 | -0.73 | -0.82 | -0.29 |
| Weighted Avg Shares Out | 20,728 | 20,404 | 10,570 | 10,480 |
| Weighted Avg Shares Out Dil | 20,728 | 20,432 | 10,570 | 10,480 |
| Supplemental Information | – | – | – | – |
| Interest Income | $333 | $2 | $9 | $106 |
| Interest Expense | $48 | $677 | $765 | $48 |
| Depreciation & Amortization | $333 | $171 | -$1,187 | -$143 |
| EBITDA | -$29,697 | -$13,828 | -$11,446 | -$9,134 |
| % Margin | -3,114.7% | -41,820.4% | -24,598.5% | -3,653.7% |